I have four new stocks for you in this issue, including two stocks that have not appeared in the Cabot Value Model in recent years. The performance of many blue-chip stocks was disappointing in 2015, but very often what goes down one year, goes up the following year. Thus, I believe my new stocks, CVS Health and FedEx, along with my other undervalued, blue-chip Model stocks will shine in 2016.
